Hem › Diffus sklerodermi › Kalifornien
Kliniska studier för Diffus sklerodermi i Kalifornien
9 studier för Diffus sklerodermi söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
Officiell studietext (engelska)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- UCLA, Los Angeles
- Hoag Hospital, Newport Beach
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06470048EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- EncompaSSc site in La Jolla, CA, La Jolla
- EncompaSSc site in Loma Linda, CA, Loma Linda
- University of California Los Angeles Scleroderma Center, Los Angeles
- och 2 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT07287670A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Los Angeles
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- och 1 fler
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05878717A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06925542Platform Clinical Study for Conquering Scleroderma
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University Medical Center, Palo Alto
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Orange
RekryterarFas 1/2
Ålder 18 till 75 · Alla kön · Uppdaterad 7 aug. 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Chula Vista, Chula Vista
- Artiva Investigational Site Covina, Covina
- Artiva Investigational Site Los Alamitos, Los Alamitos
- och 3 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT06991114Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.